Long intergenic noncoding RNAs: new links in cancer progression - PubMed (original) (raw)

Review

Long intergenic noncoding RNAs: new links in cancer progression

Miao-Chih Tsai et al. Cancer Res. 2011.

Abstract

The process of cancer metastasis involves a series of sequential and complex steps. Here we give a perspective on recent results regarding noncoding transcription in cancer progression, focusing on the emerging role of long intergenic noncoding RNAs (lincRNAs). LincRNAs target chromatin modification complexes or RNA-binding proteins to alter gene expression programs. Similarly to miRNAs, lincRNAs exhibit distinct gene expression patterns in primary tumors and metastases. We discuss how lincRNAs can be used for cancer diagnosis and prognosis and serve as potential therapeutic targets.

© 2011 AACR.

PubMed Disclaimer

Figures

Figure 1. Targeting cancer specific ncRNAs

Small molecules and complimentary antagomir sequences have been identified that bind to miRNAs, disrupting base pairing. We speculate that targeting the lincRNA structure could inhibit binding to chromatin modifying complexes, without disrupting the binding of different RNAs.

Similar articles

• Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression.
  Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D, Thomas K, Presser A, Bernstein BE, van Oudenaarden A, Regev A, Lander ES, Rinn JL. Khalil AM, et al. Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11667-72. doi: 10.1073/pnas.0904715106. Epub 2009 Jul 1. Proc Natl Acad Sci U S A. 2009. PMID: 19571010 Free PMC article.
• Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer.
  Chen Y, Lin Y, Shu Y, He J, Gao W. Chen Y, et al. Mol Cancer. 2020 May 22;19(1):94. doi: 10.1186/s12943-020-01207-4. Mol Cancer. 2020. PMID: 32443966 Free PMC article. Review.
• Systematic identification and characterization of cardiac long intergenic noncoding RNAs in zebrafish.
  Wang L, Ma X, Xu X, Zhang Y. Wang L, et al. Sci Rep. 2017 Apr 28;7(1):1250. doi: 10.1038/s41598-017-00823-3. Sci Rep. 2017. PMID: 28455512 Free PMC article.
• The interplay between m6A RNA methylation and noncoding RNA in cancer.
  Ma S, Chen C, Ji X, Liu J, Zhou Q, Wang G, Yuan W, Kan Q, Sun Z. Ma S, et al. J Hematol Oncol. 2019 Nov 22;12(1):121. doi: 10.1186/s13045-019-0805-7. J Hematol Oncol. 2019. PMID: 31757221 Free PMC article. Review.
• Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis.
  Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, Li R, West RB, van de Vijver MJ, Sukumar S, Chang HY. Gupta RA, et al. Nature. 2010 Apr 15;464(7291):1071-6. doi: 10.1038/nature08975. Nature. 2010. PMID: 20393566 Free PMC article.

Cited by

• DeepIMAGER: Deeply Analyzing Gene Regulatory Networks from scRNA-seq Data.
  Zhou X, Pan J, Chen L, Zhang S, Chen Y. Zhou X, et al. Biomolecules. 2024 Jun 27;14(7):766. doi: 10.3390/biom14070766. Biomolecules. 2024. PMID: 39062480 Free PMC article.
• Correlations of m6A Methylation-Related lncRNAs with the Prognosis of Papillary Thyroid Carcinoma.
  Li X, Ding Z, Tong Y. Li X, et al. Int J Gen Med. 2024 Mar 5;17:775-790. doi: 10.2147/IJGM.S449827. eCollection 2024. Int J Gen Med. 2024. PMID: 38476625 Free PMC article.
• YY1-induced lncRNA00511 promotes melanoma progression via the miR-150-5p/ADAM19 axis.
  Chen YN, Fu XR, Guo H, Fu XY, Shi KS, Gao T, Yu HQ. Chen YN, et al. Am J Cancer Res. 2024 Feb 15;14(2):809-831. doi: 10.62347/VRBK1334. eCollection 2024. Am J Cancer Res. 2024. PMID: 38455406 Free PMC article.
• DHRS4-AS1 regulate gastric cancer apoptosis and cell proliferation by destabilizing DHX9 and inhibited the association between DHX9 and ILF3.
  Xiao L, Zhang Y, Luo Q, Guo C, Chen Z, Lai C. Xiao L, et al. Cancer Cell Int. 2023 Dec 1;23(1):304. doi: 10.1186/s12935-023-03151-x. Cancer Cell Int. 2023. PMID: 38041141 Free PMC article.
• Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis.
  Li H, Jiang H, Huang Z, Chen Z, Chen N. Li H, et al. Aging (Albany NY). 2023 Aug 23;15(16):8325-8344. doi: 10.18632/aging.204972. Epub 2023 Aug 23. Aging (Albany NY). 2023. PMID: 37616061 Free PMC article.

References

1. 1. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003;3:453–458. - PubMed
2. 1. Birney E, Stamatoyannopoulos JA, Dutta A, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature. 2007;447:799–816. - PMC - PubMed
3. 1. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem. 2010;79:351–379. - PubMed
4. 1. Hermeking H. p53 enters the microRNA world. Cancer Cell. 2007;12:414–418. - PubMed
5. 1. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–838. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

• HHMI/Howard Hughes Medical Institute/United States
• R01 CA118750-04/CA/NCI NIH HHS/United States
• T32-AR007422/AR/NIAMS NIH HHS/United States
• R01-CA118750/CA/NCI NIH HHS/United States
• R01 CA118750/CA/NCI NIH HHS/United States
• T32 AR007422/AR/NIAMS NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations